Does normalizing PSA after successful treatment of chronic prostatitis with high PSA value exclude prostatic biopsy?
- PMID: 26816704
- PMCID: PMC4708243
- DOI: 10.3978/j.issn.2223-4683.2012.07.02
Does normalizing PSA after successful treatment of chronic prostatitis with high PSA value exclude prostatic biopsy?
Abstract
Objective: Evaluate male patients with diagnosed chronic prostatitis, elevated serum prostate-specific antigen (PSA) to find out whether medical treatment with antibiotics and anti-inflammatory drugs can lower serum PSA, and consequently decrease the prostate cancer detection rate in patients with post-treatment PSA<4 ng/mL.
Materials and methods: This prospective study evaluated 142 male patients aged 40-73 years whose presented with elevated serum PSA>4 ng/mL and were consequently diagnosed with chronic prostatitis as expressed prostatic excretions examination revealed more than 10 white blood cells per high power field. The Patients underwent treatment with antibiotics and nonsteroidal anti-inflammatory agents for 6-weeks. Subsequently, all patients are Followed-up by serum PSA and performed transrectal ultrasonography-guided prostate biopsy within 2 months of treatment.
Results: Mean patient age was (54.4±13.5) years. The mean PSA pretreatment was (8.11±3.7) ng/mL and after treatment, the mean PSA denoted a significant decrease to (4.7±3.5) ng/mL (P=0.002). The percent of changes in mean PSA was 41.9%. Prostatic biopsy after treatment showed that, cancer prostate in 31 patients (21.8%), chronic prostatitis in 71 patients (50.7%), chronic prostatitis plus benign prostatic hyperplasia (BPH) in 31 (21.8%) and BPH in 9 patients (6.3%) With regard to PSA values, cancer prostate patients were 3/25 (12%) if PSA<2.5 ng/mL, 6/47 (12.7%) if 4.0>PSA≥2.5 and 21/70 (30%) if PSA≥4.0. The numbers of cancer prostate detected patients were 30 (21.1%).
Conclusions: Chronic prostatitis is one of the causes that elevate serum PSA levels. Treatment of chronic prostatitis with elevated PSA by antibiotics and anti-inflammatory agents can decrease the elevated PSA to the normal levels. Nevertheless, the opportunities of potential prostate cancer still exist in patients with a decreased PSA level even also if PSA<2.5 ng/mL.
Keywords: Prostate-specific antigen; biopsy; cancer prostate; prostatitis.
Conflict of interest statement
Similar articles
-
Prostate Cancer Can Be Detected Even in Patients with Decreased PSA Less than 2.5 ng/ml after Treatment of Chronic Prostatitis.Korean J Urol. 2011 Jul;52(7):457-60. doi: 10.4111/kju.2011.52.7.457. Epub 2011 Jul 24. Korean J Urol. 2011. PMID: 21860765 Free PMC article.
-
Treatment of chronic prostatitis lowers serum prostate specific antigen.J Urol. 2002 Apr;167(4):1723-6. J Urol. 2002. PMID: 11912396
-
Detection of prostate cancer and changes in prostate-specific antigen (PSA) six months after surgery for benign prostatic hyperplasia in patients with elevated PSA.Urol Int. 2003;71(2):150-3. doi: 10.1159/000071837. Urol Int. 2003. PMID: 12890951
-
The issue of prostate cancer evaluation in men with elevated prostate-specific antigen and chronic prostatitis.Andrologia. 2008 Apr;40(2):130-3. doi: 10.1111/j.1439-0272.2007.00820.x. Andrologia. 2008. PMID: 18336465 Review.
-
[Asymptomatic prostatitis: a frequent cause of raising PSA].Recenti Prog Med. 2005 Jul-Aug;96(7-8):365-9. Recenti Prog Med. 2005. PMID: 16209120 Review. Italian.
Cited by
-
A Longitudinal Study of the Relationship between Shift Work and Prostate-Specific Antigen in Healthy Male Workers.Int J Environ Res Public Health. 2021 Jul 13;18(14):7458. doi: 10.3390/ijerph18147458. Int J Environ Res Public Health. 2021. PMID: 34299909 Free PMC article.
-
Antibiotic therapy in patients with high prostate-specific antigen: Is it worth considering? A systematic review.Arab J Urol. 2019 Oct 25;18(1):1-8. doi: 10.1080/2090598X.2019.1677296. eCollection 2020. Arab J Urol. 2019. PMID: 32082627 Free PMC article. Review.
-
Long-term follow-up results of multiparametric prostate MRI and the prognostic value of PI-RADS: a single-center retrospective cohort study.Diagn Interv Radiol. 2024 May 13;30(3):139-151. doi: 10.4274/dir.2023.232414. Epub 2023 Sep 19. Diagn Interv Radiol. 2024. PMID: 37724756 Free PMC article.
-
Characterization of proteins, mRNAs, and miRNAs of circulating extracellular vesicles from prostate cancer patients compared to healthy subjects.Front Oncol. 2022 Dec 8;12:895555. doi: 10.3389/fonc.2022.895555. eCollection 2022. Front Oncol. 2022. PMID: 36568159 Free PMC article.
References
-
- Roberts RO, Bergstralh EJ, Lieber MM, et al. Digital rectal examination and prostate-specific antigen abnormalities at the time of prostate biopsy and biopsy outcomes, 1980 to 1997. Urology 2000;56:817-22. - PubMed
-
- Catalona WJ, Ramos CG, Carvalhal GF, et al. Lowering PSA cutoffs to enhance detection of curable prostate cancer. Urology 2000;55:791-5. - PubMed
-
- Dalton DL. Elevated serum prostate-specific antigen due to acute bacterial prostatitis. Urology 1989;33:465. - PubMed
-
- Cho IR, Kim GJ, Park SS, et al. PSA and Prostatitis in Men under 45 Years Old. Korean J Urol 1998;39:633-7.
-
- Ozden C, Ozdal OL, Guzel O, et al. The correlation between serum prostate specific antigen levels and asymptomatic inflammatory prostatitis. Int Urol Nephrol 2007;39:859-63. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous